Robbins Geller Rudman and Dowd LLP, Paul Weiss Rifkind Wharton & Garrison, LLP,Levi & Korsinsky, LLP, Pomerantz LLP and Rosen Law Firm, P.A. P.C. assisted the...
Gordon v. Vanda Pharms. Inc.
Hellman & Friedman’s $1 Billion Acquisition of Cardinal Health’s Cordis Business
Skadden, Arps, Slate, Meagher & Flom LLP and Jones Day advised Cardinal Health, while Kirkland & Ellis LLP advised Hellman & Friedman on the deal. Cardinal...
Ibere Pharmaceuticals’ $138 Million Initial Public Offering
Shearman & Sterling advised Ibere Pharmaceuticals on the deal. Ibere Pharmaceuticals, a blank check company formed for the purpose of effecting a merger in the pharmaceutical...
Icertis’ $80 Million Series F Round
Fenwick & West LLP advised Icertis on the deal. Icertis, a contract intelligence company that pushes the boundaries of what’s possible with contract lifecycle management, announced its...
IsZo Capital v. Nam Tai Property et al.
Olshan Frome Wolosky LLP successfully represented IsZo Capital in the case. IsZo Capital, a significant long-term shareholder of Nam Tai Property Inc., prevailed in its lawsuit against...
Mayfair Gold Corp.’s $20 Million Initial Public Offering
Wildeboer Dellelce LLP acted for the Underwriters in connection with the offering. Mayfair Gold Corp., a Canada based mineral exploration company, completed an initial public offering...
Monte Rosa Therapeutics’ $95 Million Series C Financing
Goodwin Procter LLP advised Monte Rosa Therapeutics on the deal. Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing...
Nimble Robotics’ $50 Million Series A Financing
Fenwick & West LLP advised Nimble Robotics Inc. on the deal. Nimble Robotics Inc., a robotics and e-commerce fulfillment technology company, announced its $50 million Series A...
Nurix Therapeutics’ $160.4 Million Follow-on Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Nurix Therapeutics, Inc. completed its follow-on offering of 5,175,000 shares...
Shanghai Haohai Biological Technology’s $40 Million Investment in Eirion Therapeutics
Locke Lord LLP advised Shanghai Haohai Biological Technology Co. on the deal. Shanghai Haohai Biological Technology Co., Ltd., a public company traded on the Hong Kong...
Silvergate Capital’s $300 Million At-The-Market Offering
Davis Polk advised the sales agents in the offering while Holland & Knight represented Silvergate Capital Corporation. Silvergate Capital Corporation executed its at-the-market offering of shares of...
Snapcommerce’s US$85 Million Financing Round
Osler, Hoskin & Harcourt LLP advised Snapcommerce on the transaction. On March 4, 2021, Snapcommerce announced it had completed its US$85 million financing round. The funding...